Related Experiment Video
Updated: Apr 15, 2026

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
Published on: June 17, 2015
The elusive nature and diagnostics of misfolded Aβ oligomers
Eleonora Cerasoli1, Maxim G Ryadnov1, Brian M Austen2
1Biotechnology Department, National Physical Laboratory Teddington, UK.
Abstract:
Amyloid-beta (Aβ) peptide oligomers are believed to be the causative agents of Alzheimer's disease (AD). Though post-mortem examination shows that insoluble fibrils are deposited in the brains of AD patients in the form of intracellular (tangles) and extracellular (plaques) deposits, it has been observed that cognitive impairment is linked to synaptic dysfunction in the stages of the illness well before the appearance of these mature deposits. Increasing evidence suggests that the most toxic forms of Aβ are soluble low-oligomer ligands whose amounts better correlate with the extent of cognitive loss in patients than the amounts of fibrillar insoluble forms. Therefore, these ligands hold the key to a better understanding of AD prompting the search for clearer correlations between their structure and toxicity. The importance of such correlations and their diagnostic value for the early diagnosis of AD is discussed here with a particular emphasis on the transient nature and structural plasticity of misfolded Aβ oligomers.
Insights
Soluble amyloid-beta (Aβ) oligomers, not just insoluble plaques, are key drivers of Alzheimer's disease (AD) cognitive decline. Understanding their structure and toxicity is crucial for early AD diagnosis.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Alzheimer's disease (AD) is linked to amyloid-beta (Aβ) peptide deposits.
- Cognitive impairment in AD correlates with synaptic dysfunction preceding mature plaque formation.
Purpose of the Study:
- Investigate the role of soluble Aβ oligomers in Alzheimer's disease pathogenesis.
- Explore the correlation between Aβ oligomer structure, toxicity, and cognitive decline.
- Highlight the diagnostic potential of soluble Aβ oligomers for early AD detection.
Main Methods:
- Review of current evidence on Aβ oligomer formation and toxicity.
- Analysis of correlations between soluble Aβ oligomer levels and cognitive impairment.
- Discussion of the structural plasticity and transient nature of misfolded Aβ oligomers.
Main Results:
- Soluble, low-oligomer Aβ ligands show a stronger correlation with cognitive loss than insoluble fibrillar forms.
- The toxicity of Aβ oligomers is linked to their specific structures.
- Early synaptic dysfunction is associated with soluble Aβ oligomers.
Conclusions:
- Soluble Aβ oligomers are critical toxic species in Alzheimer's disease.
- Understanding the structure-toxicity relationship of Aβ oligomers is vital for early AD diagnosis.
- The transient and plastic nature of Aβ oligomers presents challenges and opportunities for diagnostics.
More Related Videos
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Export of Misfolded Proteins out of the ER
Molecular Chaperones and Protein Folding
The...
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
The Unfolded Protein Response